Menlo Therapeutics Inc. Business Operations Contracts & Agreements
10 Contracts & Agreements
- Collaboration Agreements (2 contracts)
- Indemnification Agreements (2)
- Sales Agreements (2)
- Services Agreements (1)
- Termination Agreements (1)
- Voting Agreements (2)
- Sales Agreement, dated as of (Filed With SEC on March 1, 2024)
- Controlled Equity Offering Sales AgreementSM, dated August 12, 2021, by and between VYNE Therapeutics Inc. and Cantor Fitzgerald & Co (Filed With SEC on August 12, 2021)
- Termination of Employment Agreement and Release, dated as of March 22, 2020, by and between Foamix Pharmaceuticals Ltd. and Ilan Hadar (Filed With SEC on May 11, 2020)
- Form of Foamix Voting Agreement, dated November 10, 2019, by and between Menlo Therapeutics Inc. and certain shareholders of Foamix Pharmaceuticals Ltd (Filed With SEC on November 12, 2019)
- Form of Menlo Voting Agreement, dated November 10, 2019, by and between Foamix Pharmaceuticals Ltd. and certain stockholders of Menlo Therapeutics Inc (Filed With SEC on November 12, 2019)
- Professional Services Agreement, dated June 1, 2019, by and between the Company and Mary Spellman, M.D (Filed With SEC on August 1, 2019)
- License and Collaboration Agreement, dated as of August 10, 2016, by and among the Company, Torii Pharmaceutical Co. Ltd. and Japan Tobacco, Inc (Filed With SEC on January 18, 2018)
- Form of Indemnification Agreement for directors and executive officers to be entered into following the offering (Filed With SEC on December 28, 2017)
- Form of Indemnification Agreement entered into between the Company and each of its directors and executive officers (Filed With SEC on December 28, 2017)
- License and Collaboration Agreement, dated as of August 10, 2016, by and among the Company, Torii Pharmaceutical Co. Ltd. and Japan Tobacco, Inc (Filed With SEC on December 28, 2017)
